In June 2019, the European Federation of Pharmaceutical Industries and Associations (EFPIA) consolidated its three EFPIA Codes (HCP – PO – Disclosure) into one simplified Code. Member Associations are asked to transpose the revised Code provisions by 30 June 2020 and must implement it by no later than 31 December 2020.
The objectives of this consolidation were the simplification of concepts, the removal of repetitive provisions, and the clarification of the content This exercise has been conducted to update the Code provisions for a better concept alignment and to better promote the common understanding of the Code by stakeholders and the general public aiming to improve adherence to the Code.
The EFPIA Code constitutes the collection of ethical rules agreed by EFPIA members for the Promotion of Medicinal Products to HCPs and the interactions with HCPs, HCOs and POs, with the intent of guaranteeing that these activities are conducted while respecting the most stringent ethical principles of professionalism and responsibility. This Code applies to all types of communication and interaction (traditional and digital).
Collaboration between pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) benefits patients. It is a relationship that has delivered numerous innovative medicines and changed the way many diseases impact on our lives.
Furthermore, patient organisations (POs) play a critical role in Europe’s healthcare: from prevention and awareness, through research and development, regulatory and HTA decision making, to service design and outcomes measurement.
Bringing greater transparency to this already well-regulated and vital relationship, builds understanding of industry-POs and HCPs/HCOs collaboration and, in the context of increasing societal expectations on transparency, addresses directly public concerns about interactions between the medical community and the pharmaceutical industry.
That is why, on a voluntary basis, EFPIA has decided to disclose the amounts provided to POs, HCPs and HCOs.